← Back to Calendar

ASCO Annual Meeting 2026

American Society of Clinical Oncology

Standard Review Major Conference

PDUFA Date

May 29, 2026

Time Remaining

66 days

Review Type

Standard (10 mo)

Indication

Clinical Oncology — Chicago, IL

Key Notes

ASCO Annual Meeting 2026: May 29 – June 2, Chicago. Largest oncology conference globally — multiple Phase 3 readouts and pivotal trial presentations across all tumor types. Key presentations expected: zovegalisib (RLAY), ifinatamab deruxtecan (I-DXd), bezuclastinib (COGT). Late-breaking abstracts often move stocks significantly.

⚠️ Not Investment Advice: This information is provided for educational purposes only. PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period, issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on historical base rates and do not account for drug-specific factors. Always consult a financial advisor before making investment decisions.

← Back to Full Calendar